About
Company
Contact Us
History
Careers
Policies
Editorial Policies
Open Access Policy
Publication Fees
Research and Publication Ethics
Advertising Policy
Journals
All Journals
Activite Journals
Archived Journals
Services
Submission System
Collaborations
Journal Membership
Conference Parterships
Insights
Latest Articles
Academic Talks
Interactive Webinars
Latest News
Search
Log in
Home
Volumes
Volume 8 (2022)
Volume
Volume 8 (2022) – 48 articles
Cover Picture:
Coming soon.
view this paper
Editorial
New developments in management of metastatic thyroid cancer
Jerome M. Hershman
This article belongs to the Special Issue
Mechanism and Treatment of Thyroid Cancer
J Cancer Metastasis Treat
2022;8:3. DOI:
10.20517/2394-4722.2021.156
Editorial | Published on: 24 Jan 2022
Review
Promising therapeutic potential of tumor suppressor microRNAs for malignant pleural mesothelioma
Shivani Dixit, ... Chuong D. Hoang
This article belongs to the Special Issue
Research Advances on Mesothelioma
J Cancer Metastasis Treat
2022;8:47. DOI:
10.20517/2394-4722.2022.70
Review | Published on: 4 Dec 2022
Immunotherapy in malignant pleural mesothelioma: a long story ended in success
Alberto Bongiovanni
, ... Luana Calabrò
This article belongs to the Special Issue
Research Advances on Mesothelioma
J Cancer Metastasis Treat
2022;8:44. DOI:
10.20517/2394-4722.2022.78
Review | Published on: 7 Oct 2022
Peritoneal mesothelioma
Yutaka Yonemura, ... Daisuke Fujimoto
This article belongs to the Special Issue
Research Advances on Mesothelioma
J Cancer Metastasis Treat
2022;8:43. DOI:
10.20517/2394-4722.2022.49
Review | Published on: 27 Sep 2022
The heterogeneity of CAFs and immune cell populations in the tumor microenvironment of pancreatic adenocarcinoma
Maria Diab
, Bassel F. El-Rayes
This article belongs to the Special Issue
Role of Immune Cells in the Tumor Microenvironment
J Cancer Metastasis Treat
2022;8:42. DOI:
10.20517/2394-4722.2022.60
Review | Published on: 26 Sep 2022
Telemedicine for sarcoma patient care
Scott M. Schuetze
J Cancer Metastasis Treat
2022;8:41. DOI:
10.20517/2394-4722.2022.38
Review | Published on: 26 Sep 2022
The role of modern immunotherapy in metastatic urothelial cancer: mini review
Francesca Jackson-Spence
, ... Thomas Powles
J Cancer Metastasis Treat
2022;8:40. DOI:
10.20517/2394-4722.2022.50
Review | Published on: 25 Sep 2022
The role of radiation therapy in the management of primary thymic epithelial neoplasms
Candice Johnstone, Charles B. Simone
This article belongs to the Special Issue
The Pathology of Thymic Epithelial Tumors
J Cancer Metastasis Treat
2022;8:39. DOI:
10.20517/2394-4722.2021.211
Review | Published on: 18 Sep 2022
Neoadjuvant treatment of pancreatic ductal adenocarcinoma: present and future
Ioannis M. Koukourakis, ... Christos Papadimitriou
This article belongs to the Special Issue
Treatment of Pancreatic Cancer
J Cancer Metastasis Treat
2022;8:38. DOI:
10.20517/2394-4722.2022.43
Review | Published on: 17 Sep 2022
Updates on the pathologic diagnosis and classification of mesothelioma
Julia R. Farkas, ... Jefree J. Schulte
This article belongs to the Special Issue
Research Advances on Mesothelioma
J Cancer Metastasis Treat
2022;8:37. DOI:
10.20517/2394-4722.2022.89
Review | Published on: 8 Sep 2022
Reactive oxygen species in the progression and treatment of malignant mesothelioma
Ava Cote, ... Brian Cunniff
This article belongs to the Special Issue
Research Advances on Mesothelioma
J Cancer Metastasis Treat
2022;8:36. DOI:
10.20517/2394-4722.2022.41
Review | Published on: 30 Aug 2022
Treatment strategies in cervical cancer: treatment of advanced disease
Augusto Valdivia, ... Ana Oaknin
This article belongs to the Special Issue
Treatment Strategies of Cervical Cancer
J Cancer Metastasis Treat
2022;8:35. DOI:
10.20517/2394-4722.2022.34
Review | Published on: 24 Aug 2022
Determinants of prognosis in metastatic urothelial carcinoma: a review of the literature
Gavin Hui
, ... Petros Grivas
J Cancer Metastasis Treat
2022;8:34. DOI:
10.20517/2394-4722.2022.04
Review | Published on: 21 Aug 2022
A shifting adversary: control of pancreatic cancer transcriptomic subtypes
Charles J. David
This article belongs to the Special Issue
Treatment of Pancreatic Cancer
J Cancer Metastasis Treat
2022;8:32. DOI:
10.20517/2394-4722.2022.71
Review | Published on: 21 Aug 2022
Germline predisposition to soft tissue sarcoma
Jennie Vagher, ... Luke Maese
J Cancer Metastasis Treat
2022;8:31. DOI:
10.20517/2394-4722.2022.31
Review | Published on: 18 Aug 2022
The role of systemic therapy in borderline resectable and locally advanced pancreatic ductal adenocarcinoma
Victor C. K. Lo, ... Michael M. Vickers
This article belongs to the Special Issue
Treatment of Pancreatic Cancer
J Cancer Metastasis Treat
2022;8:30. DOI:
10.20517/2394-4722.2022.48
Review | Published on: 14 Aug 2022
Utility of circulating tumor DNA for predicting prognosis in the management of resectable pancreatic cancer
Zachary Tyerman, ... Akhil Chawla
This article belongs to the Special Issue
Treatment of Pancreatic Cancer
J Cancer Metastasis Treat
2022;8:29. DOI:
10.20517/2394-4722.2022.20
Review | Published on: 28 Jul 2022
Overcoming tumor antigen heterogeneity in
CAR-T cell
therapy for malignant mesothelioma (MM)
Reena R. D'Souza
, ... Astero Klampatsa
This article belongs to the Special Issue
Research Advances on Mesothelioma
J Cancer Metastasis Treat
2022;8:28. DOI:
10.20517/2394-4722.2022.51
Review | Published on: 27 Jul 2022
Role of myeloid cells in the tumor microenvironment
Arpita Balakrishnan, ... Shweta Dubey
This article belongs to the Special Issue
Role of Immune Cells in the Tumor Microenvironment
J Cancer Metastasis Treat
2022;8:27. DOI:
10.20517/2394-4722.2022.33
Review | Published on: 25 Jul 2022
Current and future opportunities for liquid biopsy of circulating biomarkers to aid in early cancer detection
Susan H. Gawel, ... Gerard J. Davis
This article belongs to the Special Issue
Liquid Biopsies in Cancer Early Diagnosis
J Cancer Metastasis Treat
2022;8:26. DOI:
10.20517/2394-4722.2022.13
Review | Published on: 28 Jun 2022
The peripheral T-cell lymphoma: can we pivot from the chemotherapy-predicated paradigm?
Helen Ma
, Enrica Marchi
This article belongs to the Special Issue
Advancing the Care of Non-Hodgkins Lymphoma (NHL): Steps Towards Being Chemo-Free
J Cancer Metastasis Treat
2022;8:25. DOI:
10.20517/2394-4722.2022.17
Review | Published on: 28 Jun 2022
The role of VISTA in the tumor microenvironment
Dina Rabadi
, ... J. Louise Lines
This article belongs to the Special Issue
Role of Immune Cells in the Tumor Microenvironment
J Cancer Metastasis Treat
2022;8:24. DOI:
10.20517/2394-4722.2022.06
Review | Published on: 21 Jun 2022
Lymph node metastasis from non-melanoma skin cancer
Robbie S. R. Woods, ... Jatin P. Shah
This article belongs to the Special Issue
Lymph Node Metastases in the Neck
J Cancer Metastasis Treat
2022;8:22. DOI:
10.20517/2394-4722.2022.28
Review | Published on: 26 May 2022
Follicular lymphoma: the diminishing role of chemotherapy
Beatrice Casadei, ... Pier Luigi Zinzani
This article belongs to the Special Issue
Advancing the Care of Non-Hodgkins Lymphoma (NHL): Steps Towards Being Chemo-Free
J Cancer Metastasis Treat
2022;8:21. DOI:
10.20517/2394-4722.2022.05
Review | Published on: 25 May 2022
Tumors due to chronic exposure to benzene and biomarkers of exposure
Gilda Alves
, ... Maria Helena Faria Ornellas
J Cancer Metastasis Treat
2022;8:20. DOI:
10.20517/2394-4722.2022.02
Review | Published on: 19 May 2022
Molecular pathology of thymoma and thymic carcinoma
David I. Suster, ... A. Craig Mackinnon
This article belongs to the Special Issue
The Pathology of Thymic Epithelial Tumors
J Cancer Metastasis Treat
2022;8:19. DOI:
10.20517/2394-4722.2021.210
Review | Published on: 16 May 2022
Anti-angiogenic drugs in cancer therapeutics: a review of the latest preclinical and clinical studies of anti-angiogenic agents with anticancer potential
Polyxeni Vafopoulou, Malamati Kourti
This article belongs to the Special Issue
Research Advances on Tumor-Induced Angiogenesis
J Cancer Metastasis Treat
2022;8:18. DOI:
10.20517/2394-4722.2022.08
Review | Published on: 5 May 2022
Combining oncolytic virus and radiation therapy for cancer management
Vito Filbert Jayalie
, Sri Mutya Sekarutami
J Cancer Metastasis Treat
2022;8:17. DOI:
10.20517/2394-4722.2021.212
Review | Published on: 28 Apr 2022
Thymic carcinoma: review and update
Kirill Karlin, Phillip D. Michaels
This article belongs to the Special Issue
The Pathology of Thymic Epithelial Tumors
J Cancer Metastasis Treat
2022;8:15. DOI:
10.20517/2394-4722.2021.185
Review | Published on: 7 Apr 2022
Chronic activation of MUC1-C in wound repair promotes progression to cancer stem cells
Donald W. Kufe
J Cancer Metastasis Treat
2022;8:12. DOI:
10.20517/2394-4722.2022.03
Review | Published on: 30 Mar 2022
Diffuse large B-Cell lymphoma: from novel molecular classifications to tailored targeted therapies
Jennifer K. Lue, Grzegorz S. Nowakowski
This article belongs to the Special Issue
Advancing the Care of Non-Hodgkins Lymphoma (NHL): Steps Towards Being Chemo-Free
J Cancer Metastasis Treat
2022;8:11. DOI:
10.20517/2394-4722.2021.193
Review | Published on: 30 Mar 2022
The bone marrow niche landscape: a journey through aging, extrinsic and intrinsic stressors in the haemopoietic milieu
Antonio Giovanni Solimando
, ... Roberto Ria
This article belongs to the Special Issue
Angiogenesis and Antiangiogenesis in Hematological Malignancies
J Cancer Metastasis Treat
2022;8:9. DOI:
10.20517/2394-4722.2021.166
Review | Published on: 17 Mar 2022
The WHO 2021 thymoma classification: a work in progress
Saul Suster
This article belongs to the Special Issue
The Pathology of Thymic Epithelial Tumors
J Cancer Metastasis Treat
2022;8:7. DOI:
10.20517/2394-4722.2021.203
Review | Published on: 11 Mar 2022
The role of radiotherapy in metastatic bladder cancer
Jananie Perera, Peter Hoskin
J Cancer Metastasis Treat
2022;8:4. DOI:
10.20517/2394-4722.2021.167
Review | Published on: 24 Jan 2022
The role of MT1-MMP in the progression and metastasis of osteosarcoma
Hannah L. M. Spencer, ... Robert A. Falconer
This article belongs to the Special Issue
Bone Microenvironment and Bone Metastasis
J Cancer Metastasis Treat
2022;8:2. DOI:
10.20517/2394-4722.2021.174
Review | Published on: 13 Jan 2022
Biomarkers for therapy selection in metastatic urothelial cancer
Tomi Jun, ... Matthew D. Galsky
J Cancer Metastasis Treat
2022;8:1. DOI:
10.20517/2394-4722.2021.171
Review | Published on: 11 Jan 2022
Original Article
Diagnostic accuracy of MRI and PET/CT for neck staging prior to salvage total laryngectomy
Jonas Galli
, ... Lluís Nisa
This article belongs to the Special Issue
Lymph Node Metastases in the Neck
J Cancer Metastasis Treat
2022;8:48. DOI:
10.20517/2394-4722.2022.19
Original Article | Published on: 22 Dec 2022
The safety and efficacy of palbociclib in older patients with advanced breast cancer in a real-world setting
Etienne Gouton, ... Frederique Rousseau
This article belongs to the Special Issue
Breast Cancer Metastasis
J Cancer Metastasis Treat
2022;8:33. DOI:
10.20517/2394-4722.2022.64
Original Article | Published on: 21 Aug 2022
Sensitivity of MCF-7 mammosphere CSCs to neutron radiation
Valentina G. Shuvatova, ... Elizaveta Yu Moskaleva
J Cancer Metastasis Treat
2022;8:23. DOI:
10.20517/2394-4722.2022.29
Original Article | Published on: 29 May 2022
Surgical route and pathological risk factors in early cervical cancer - Node Zero (SURPEC-N0)
T S Shylasree, ... Rajendra Kerkar
This article belongs to the Special Issue
Treatment Strategies of Cervical Cancer
J Cancer Metastasis Treat
2022;8:14. DOI:
10.20517/2394-4722.2022.10
Original Article | Published on: 6 Apr 2022
Final results of a 2:1 control-case observational study using interferon beta and interleukin-2, in addition to first-line hormone therapy, in estrogen receptor-positive, endocrine-responsive metastatic breast cancer patients
Andrea Nicolini, ... Angelo Carpi
J Cancer Metastasis Treat
2022;8:13. DOI:
10.20517/2394-4722.2021.209
Original Article | Published on: 6 Apr 2022
Combined effects of oncolytic vaccinia virus and dendritic cells on the progression of melanoma B16-F10 in mice
Elena P. Goncharova, ... Marina A. Zenkova
J Cancer Metastasis Treat
2022;8:10. DOI:
10.20517/2394-4722.2021.195
Original Article | Published on: 17 Mar 2022
Serum squamous cell carcinoma antigen is a predictive factor of outcomes in patients with locally advanced unresectable esophageal squamous cell carcinoma treated by definitive chemoradiotherapy
Takeshi Suzuki, ... Keisho Chin
This article belongs to the Special Issue
Management of Esophageal Cancer
J Cancer Metastasis Treat
2022;8:5. DOI:
10.20517/2394-4722.2021.160
Original Article | Published on: 24 Jan 2022
Opinion
More efficient clinical trials in pancreatic cancer: develop better treatment options, faster
Allison Rosenzweig, ... Lynn M. Matrisian
This article belongs to the Special Issue
Treatment of Pancreatic Cancer
J Cancer Metastasis Treat
2022;8:46. DOI:
10.20517/2394-4722.2022.58
Opinion | Published on: 18 Oct 2022
Radiomics in sarcoma trials: a complement to RECIST for patient assessment
Caryn Geady, ... Benjamin Haibe-Kains
J Cancer Metastasis Treat
2022;8:45. DOI:
10.20517/2394-4722.2022.57
Opinion | Published on: 7 Oct 2022
Tricking the tumour microenvironment into becoming our best rational drug design factory: reversal of immune suppression
Martin L. Ashdown
This article belongs to the Special Issue
Role of Immune Cells in the Tumor Microenvironment
J Cancer Metastasis Treat
2022;8:6. DOI:
10.20517/2394-4722.2022.01
Opinion | Published on: 27 Feb 2022
Case Report
Angiogenesis and osteopontin expression in paraskeletal myeloma with plasmablastic morphology and aggressive clinical course: a report of two cases
Toni Valković, ... Nives Jonjić
This article belongs to the Special Issue
Angiogenesis and Antiangiogenesis in Hematological Malignancies
J Cancer Metastasis Treat
2022;8:16. DOI:
10.20517/2394-4722.2021.208
Case Report | Published on: 23 Apr 2022
Perspective
Moving towards the chemo-free treatment of lymphoma: hype or reality?
Bruce D. Cheson
This article belongs to the Special Issue
Advancing the Care of Non-Hodgkins Lymphoma (NHL): Steps Towards Being Chemo-Free
J Cancer Metastasis Treat
2022;8:8. DOI:
10.20517/2394-4722.2021.153
Perspective | Published on: 17 Mar 2022
Actions for 0 selected articles
Download PDFs >
Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)
editorialoffice@jcmtjournal.com
Navigation
Contact Us
Sitemap
Follow Us
LinkedIn
Facebook
Twitter
Google Scholar
Navigation
Contact Us
Sitemap
Portico
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/
Portico
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/